That is my opinion. Yours obviously differs.
My reasons for lower FY19 revenue than current consensus is for reasons such as: the low-hanging fruit of online sales market share has largely been scooped up and therefore I see a slower grind higher on that front. Australia pharmacy and supermarket market share is already above 30% and has been floating/stable at that level for quite a while, so can't see much growth there. Offline sales into China will be a slow burn and is also a lower margin channel - similar to the slow burn in US and UK markets. The Fonterra deal won't have a material impact in 1HY19. It might provide an uplift in 2HY19, but not to the extent that some believe.
My point is that I believe a more moderate growth profile needs to be factored by the market.
I might be wrong. It's just my opinion, which is just one among a crowd ;-)
Chart Update, page-1246
-
- There are more pages in this discussion • 23,985 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.973B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $6.90 | $6.80 | $7.266M | 1.060M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12501 | $6.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.88 | 33092 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |